Evidence map›Paper›PMID 27338244›Full record

Observational studyJournal of translational medicine2016

Interaction between polyphenols intake and PON1 gene variants on markers of cardiovascular disease: a nutrigenetic observational study.

Federica Rizzi, Costanza Conti, Elena Dogliotti, Annalisa Terranegra, Erika Salvi, Daniele Braga, Flavia Ricca, Sara Lupoli, Alessandra Mingione, Francesca Pivari and 9 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Journal of translational medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. [Nutrigenetics: potentials and applications in cardiovascular diseases and associated risk factors].Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Nutrigenetics-personalized nutrition in obesity and cardiovascular diseases.International journal of obesity supplements · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

Federica RizziGenomics and Bionformatics Unit, Department of Health Sciences, Università degli Studi di Milano, viale Ortles 22/4, Milan, Italy.
Costanza ContiGenomics and Bionformatics Unit, Department of Health Sciences, Università degli Studi di Milano, viale Ortles 22/4, Milan, Italy.
Elena DogliottiDivision of Nephrology, ASST Santi Paolo e Carlo, Via Antonio di Rudinì 8, Milan, Italy.
Annalisa TerranegraDivision of Translational Medicine, Sidra Medical Research Center, Doha, Qatar.
Erika SalviGenomics and Bionformatics Unit, Department of Health Sciences, Università degli Studi di Milano, viale Ortles 22/4, Milan, Italy.
Daniele BragaGenomics and Bionformatics Unit, Department of Health Sciences, Università degli Studi di Milano, viale Ortles 22/4, Milan, Italy.
Flavia RiccaDivision of Nephrology, ASST Santi Paolo e Carlo, Via Antonio di Rudinì 8, Milan, Italy.
Sara LupoliGenomics and Bionformatics Unit, Department of Health Sciences, Università degli Studi di Milano, viale Ortles 22/4, Milan, Italy.
Alessandra MingioneDepartment of Health Sciences, Università degli Studi di Milano, Via Antonio di Rudinì 8, Milan, Italy.
Francesca PivariDepartment of Health Sciences, Università degli Studi di Milano, Via Antonio di Rudinì 8, Milan, Italy.
Caterina BrasacchioDepartment of Health Sciences, Università degli Studi di Milano, Via Antonio di Rudinì 8, Milan, Italy.
Matteo BarcellaGenomics and Bionformatics Unit, Department of Health Sciences, Università degli Studi di Milano, viale Ortles 22/4, Milan, Italy.
Martina ChittaniGenomics and Bionformatics Unit, Department of Health Sciences, Università degli Studi di Milano, viale Ortles 22/4, Milan, Italy.
Francesca D'AvilaGenomics and Bionformatics Unit, Department of Health Sciences, Università degli Studi di Milano, viale Ortles 22/4, Milan, Italy.
Maurizio TurielIRCCS Galeazzi Orthopedic Institute, Via Riccardo Galeazzi, 4, Milan, Italy.
Monica LazzaroniLaboratory of Clinical Pathology and Medical Genetics, Foundation IRCCS Neurological Institute C. Besta, Milan, Italy.
Laura SoldatiGenomics and Bionformatics Unit, Department of Health Sciences, Università degli Studi di Milano, viale Ortles 22/4, Milan, Italy.
Daniele CusiDivision of Nephrology, ASST Santi Paolo e Carlo, Via Antonio di Rudinì 8, Milan, Italy.
Cristina BarlassinaGenomics and Bionformatics Unit, Department of Health Sciences, Università degli Studi di Milano, viale Ortles 22/4, Milan, Italy. cristina.barlassina@unimi.it.
University of Milan · ITAzienda Socio Sanitaria Territoriale Santi Paolo e CarloInstitute of Genetic and Biomedical Research · ITIstituto Ortopedico Galeazzi · ITOspedale San Paolo · ITSidra Medical and Research Center · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParaoxonase 1 (PON1) gene polymorphisms and polyphenols intake have been reported independently associated to lipid profile and susceptibility to atherosclerosis and cardiovascular disease. However, the interaction between these factors remains to be investigated. We performed an observational nutrigenetic study to examine whether the interaction between polyphenols and anthocyanins intake and PON1 genetic variants can modulate biomarkers of cardiovascular health in an Italian healthy population.

methodsWe recruited 443 healthy volunteers who participated in the EC funded ATHENA project (AnThocyanin and polyphenols bioactive for Health Enhancement through Nutritional Advancement). Data collection included detailed demographic, clinical, dietary, lifestyle, biochemical and genetic data. Polyphenols and anthocyanins intake was measured by 24 h dietary recall repeated three times a year in order to get seasonal variations. We tested the interaction between 18 independent tagging SNPs in PON1 gene and polyphenols intake on HDL, LDL, cholesterol, triglycerides and atherogenic index of plasma.

resultsWithout considering the genetic background, we could not observe significant differences in the lipid profile between high and low polyphenols and anthocyanins intake. Using a nutrigenetic approach, we identified protective genotypes in four independent polymorphisms that, at Bonferroni level (p ≤ 0.0028), present a significant association with increased HDL level under high polyphenols and anthocyanins intake, compared to risk genotypes (rs854549, Beta = 4.7 per C allele; rs854552, Beta = 5.6 per C allele; rs854571, Beta = 3.92 per T allele; rs854572, Beta = 3.94 per C allele).

conclusionsWe highlight the protective role of genetic variants in PON1 towards cardiovascular risk under high polyphenols and anthocyanins consumption. PON1 variants could represent novel biomarkers to stratify individuals who might benefit from targeted dietary recommendation for health promotion and strategies of preventive medicine.

Indexed as

NutrigenomicsAdultAgedAged, 80 and overAnthocyaninsAryldialkylphosphataseBiomarkersCardiovascular DiseasesFemaleGenotypeHumansMaleMiddle AgedPhenotypePolymorphism, Single NucleotidePolyphenolsAnthocyaninsAryldialkylphosphataseBiomarkersPolyphenolsAnthocyaninsAntioxidantsGene diet interactionGenetic variantsHDLLipid profileNutrigenomicsPolyphenolsPON1 gene

Identifiers

PMID27338244
PMCPMC4918189
OpenAlexW2466482021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.